DRUG DISCOVERY 2022 ELRIG’s annual Drug Discovery meeting will be held in-person, from 4–5th October at the Excel in London, and it’s going to be bigger and better than ever. This year they will celebrate the drug discovery industry’s long history of hosting disruptive and innovative technology developments, whilst exploring the next life science evolution and the exciting prospect of driving a renaissance in the life sciences.
Their focus is on the growing life sciences revolution, advanced in no small way by the unprecedented scientific progress made during the COVID-19 pandemic. By joining them this year, you’ll have the opportunity to hear from world-leading experts, build new networks, and foster fruitful collaborations, all the while discovering the latest advancements in topics spanning screening, automation, high content imaging, disease models, and cell and gene therapies. But that’s not all. They’ve also partnered with the British Pharmacology Society (BPS), the Society for Laboratory Automation and Screening (SLAS), and the Royal Society of Chemistry (RSC) to bring you an even broader mix of topics and speakers on all aspects of drug discovery research. We’re excited. But if you aren’t yet, here are 5 reasons why you really can’t afford to miss Drug Discovery.
ACCESS THE IDEAS AND RESEARCH DRIVING A LIFE SCIENCES REVOLUTION
Across the two-day event, you’ll learn about the latest path shaping research, technologies, and approaches in drug discovery, all to keep you at the forefront of knowledge while uncovering new opportunities to streamline your own drug discovery efforts. They’ve put together eight insight-packed tracks for you to immerse yourself in, delivered by experts at leading organizations — from the Crick Institute to AstraZeneca and GlaxoSmithKline.
Join and learn about:
- Overcoming Challenges and New Directions in Medicinal Chemistry
- High Content Imaging in Drug Discovery
- Cell & Gene Therapy
- Drug Discovery and Development in COPD (content provided by the British Pharmacological Society)
- Innovation through partnership
- Frontiers of Chemistry applied to Drug Discovery (content provided by the Royal Society of Chemistry)
- Developments in Preclinical Models
- Advancements in Screening and Automation (content provided by Society for Laboratory Automation and Screening
Our colleagues Maria Guerra and Antonio Quilez will attend this meeting to learn about the latest advances in drug discovery and show you our Lab-in-a Cell devices as one of the most disruptive technologies for drug discovery processes.
nn
